2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Prostatic Intraepithelial Neoplasia in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Prostatic Intraepithelial Neoplasia: A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renner, O | 1 |
| Fominaya, J | 1 |
| Alonso, S | 1 |
| Blanco-Aparicio, C | 1 |
| Leal, JF | 1 |
| Carnero, A | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Intraepithelial Neoplasia
| Article | Year |
|---|---|
Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Chromones; Class I Phosphatidylinositol 3-Kinases; Enzym | 2007 |